ACTIVATION OF NON-MHC-RESTRICTED CYTOTOXIC LYMPHOCYTES
非 MHC 限制性细胞毒性淋巴细胞的激活
基本信息
- 批准号:2091818
- 负责人:
- 金额:$ 25.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-07-01 至 1999-04-30
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte antireceptor antibody basophils biological signal transduction cell differentiation cytokine receptors dendritic cells human tissue in situ hybridization interleukin 2 laboratory mouse leukocyte activation /transformation lymphokines monocyte natural killer cells polymerase chain reaction protein tyrosine kinase receptor expression tissue /cell culture
项目摘要
Natural Killer (NK) cells represent the major lymphocyte subset whose
functions are elicited, in the initial phases of the host response to a
variety of pathogens, and that are capable of cytotoxicity in an MHC-
non-restricted fashion. Through production of cytokines, NK cells exert
a regulatory role on other cell types and, on the other hand, their own
biological functions are regulated by cytokines produced by other
mononuclear cell subsets and, possibly, by themselves. Among the known
cytokines, only IL-2 and IL-12 have been demonstrated capable of
modulating proliferation of these cells directly. We have identified
and characterized the biological functions exerted by IL-12 on NK cells
and T lymphocytes. IL-12 is a novel cytokine that acts independently
from IL-2 to induce activation and proliferation of prestimulated NK and
T cells. It enhances spontaneous cytotoxicity of NK cells, induces
cytokine production by PBL acting in synergy with IL-2 and a series of
other stimuli, variably modulates proliferation of lymphocytes, and
affects Th1 cells differentiation. Our data support the contention that
the mechanisms by which the two cytokines affect NK and T cell functions
are distinct, and likely do depend on induction of different
intracellular activation pathways, although in both cases activation of
tyrosine kinases may play a major functional role. Understanding the
immunobiology of NK cells depends on defining the type of interactions
that are elicited to induce production of cytokines and the binding of
these to their specific receptors at the surface of the effector cells.
In order to start dissecting these conditions we propose: 1) to identify
the cell types that are involved in the production of IL-12, with
particular attention to mononuclear cell subsets present in minor
proportion among lymphocytes (e.g. B lymphocytes and their subsets,
basophils, and monocytes), using a combination of cell separation,
biochemical and molecular biology techniques; 2) to biochemically and
functionally characterize the receptor(s) for this cytokine, focusing on
understanding the basis for the receptor-mediated signal-transduction
and induced tyrosine kinase activity; and 3) to determine whether IL-12
also acts as a differentiation factor for more immature NK cell
populations, utilizing the culture system in which we have demonstrated
preferential proliferation of mature NK cells. From the proposed
studies we expect to derive relevant information to the immunobiology of
NK cells, and of cytokines that enhance the functions of this and other
cytotoxic cell types and are, at present considered for possible
immunotherapeutic use in several pathological situations.
自然杀伤(NK)细胞代表主要的淋巴细胞亚群,
在宿主响应的初始阶段,
各种病原体,并且能够在MHC中具有细胞毒性-
不受限制的时尚 通过产生细胞因子,NK细胞发挥
对其他细胞类型的调节作用,另一方面,
生物学功能由其他细胞产生的细胞因子调节。
单核细胞亚群,可能是它们自己。 在已知的
细胞因子,只有IL-2和IL-12已被证明能够
直接调节这些细胞的增殖。 我们已经确定
并表征了IL-12对NK细胞的生物学功能
和T淋巴细胞。 IL-12是一种新的细胞因子,
从IL-2诱导预刺激的NK的活化和增殖,
T细胞。 它增强NK细胞的自发细胞毒性,诱导
PBL与IL-2协同作用产生的细胞因子以及一系列的
其他刺激物可调节淋巴细胞的增殖,
影响Th 1细胞的分化。 我们的数据支持这样的论点,
两种细胞因子影响NK和T细胞功能的机制
是不同的,很可能取决于不同的诱导,
细胞内激活途径,虽然在这两种情况下,
酪氨酸激酶可能起主要的功能作用。 了解
NK细胞的免疫生物学依赖于确定相互作用的类型
其被引发以诱导细胞因子的产生和细胞因子的结合。
它们与效应细胞表面的特异性受体结合。
为了开始解剖这些条件,我们建议:1)识别
参与IL-12产生的细胞类型,
特别注意单核细胞亚群,
淋巴细胞(例如B淋巴细胞及其亚群,
嗜碱性粒细胞和单核细胞),使用细胞分离的组合,
生物化学和分子生物学技术; 2)生物化学和
功能上表征该细胞因子的受体,重点是
了解受体介导的信号转导的基础
和诱导的酪氨酸激酶活性;和3)确定IL-12是否
也作为一个分化因子为更不成熟的NK细胞
利用我们已经证明的文化系统,
成熟NK细胞的优先增殖。 从拟议
我们希望通过这些研究获得与免疫生物学相关的信息,
NK细胞,以及增强这种和其他细胞功能的细胞因子。
细胞毒性细胞类型,目前被认为是可能的
在几种病理情况下使用免疫抑制剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BICE PERUSSIA其他文献
BICE PERUSSIA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BICE PERUSSIA', 18)}}的其他基金
FLOW CYTOMETRY FACILITY HIGH SPEED SORTER: LEUKEMIA
流式细胞术设备高速分选机:白血病
- 批准号:
7166527 - 财政年份:2005
- 资助金额:
$ 25.96万 - 项目类别:
FLOW CYTOMETRY FACILITY HIGH SPEED SORTER: AIDS
流式细胞术设备高速分选机:艾滋病
- 批准号:
7166526 - 财政年份:2005
- 资助金额:
$ 25.96万 - 项目类别:
FLOW CYTOMETRY FACILITY HIGH SPEED SORTER: IMMUNOLOGY
流式细胞术设备高速分选机:免疫学
- 批准号:
7166528 - 财政年份:2005
- 资助金额:
$ 25.96万 - 项目类别:














{{item.name}}会员




